Vijay Kumar
Stock Analyst at Evercore ISI Group
(3.48)
# 926
Out of 5,090 analysts
270
Total ratings
54.27%
Success rate
2.27%
Average return
Main Sectors:
Stocks Rated by Vijay Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Maintains: Outperform | $410 → $405 | $364.02 | +11.26% | 13 | Oct 31, 2025 | |
| ILMN Illumina | Maintains: Outperform | $132 → $142 | $128.96 | +10.11% | 9 | Oct 31, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $88 → $92 | $86.19 | +6.74% | 15 | Oct 31, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Outperform | $88 → $92 | $85.46 | +7.65% | 5 | Oct 30, 2025 | |
| BLCO Bausch + Lomb | Maintains: Outperform | $17 → $18 | $16.82 | +7.02% | 11 | Oct 30, 2025 | |
| AVTR Avantor | Maintains: Outperform | $16 → $14 | $10.93 | +28.09% | 12 | Oct 30, 2025 | |
| JBHT J.B. Hunt Transport Services | Maintains: Outperform | $155 → $168 | $188.41 | -10.83% | 8 | Oct 16, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $144 → $142 | $125.08 | +13.53% | 17 | Oct 16, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: In-Line | $106 → $104 | $94.28 | +10.31% | 14 | Oct 7, 2025 | |
| TWST Twist Bioscience | Maintains: Outperform | $46 → $42 | $32.30 | +30.03% | 6 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $525 → $590 | $572.77 | +3.01% | 13 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $108 → $106 | $100.79 | +5.17% | 3 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $285 | $300.66 | -5.21% | 2 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $1,275 → $1,400 | $1,414.86 | -1.05% | 12 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $535 → $450 | $575.34 | -21.79% | 14 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $185 → $175 | $178.37 | -1.89% | 2 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $68 | $101.06 | -32.71% | 7 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $226 → $245 | $226.25 | +8.29% | 4 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $110 | $97.52 | +12.80% | 7 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $31 | $18.54 | +67.21% | 8 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $128 → $140 | $145.49 | -3.77% | 7 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $69 → $78 | $74.97 | +4.04% | 16 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $49 → $54 | $51.26 | +5.35% | 7 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $40 | $28.86 | +38.60% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $35 → $33 | $35.05 | -5.85% | 8 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $103 → $106 | $101.36 | +4.58% | 5 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $46 | $27.02 | +70.24% | 4 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $3 | $2.49 | +20.48% | 6 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $18 → $30 | $12.11 | +147.73% | 11 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $335 → $355 | $394.81 | -10.08% | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $160 | $77.63 | +106.11% | 7 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $286 → $290 | $193.96 | +49.52% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $1.08 | +548.15% | 1 | May 31, 2022 |
Stryker
Oct 31, 2025
Maintains: Outperform
Price Target: $410 → $405
Current: $364.02
Upside: +11.26%
Illumina
Oct 31, 2025
Maintains: Outperform
Price Target: $132 → $142
Current: $128.96
Upside: +10.11%
Edwards Lifesciences
Oct 31, 2025
Maintains: Outperform
Price Target: $88 → $92
Current: $86.19
Upside: +6.74%
GE HealthCare Technologies
Oct 30, 2025
Maintains: Outperform
Price Target: $88 → $92
Current: $85.46
Upside: +7.65%
Bausch + Lomb
Oct 30, 2025
Maintains: Outperform
Price Target: $17 → $18
Current: $16.82
Upside: +7.02%
Avantor
Oct 30, 2025
Maintains: Outperform
Price Target: $16 → $14
Current: $10.93
Upside: +28.09%
J.B. Hunt Transport Services
Oct 16, 2025
Maintains: Outperform
Price Target: $155 → $168
Current: $188.41
Upside: -10.83%
Abbott Laboratories
Oct 16, 2025
Maintains: Outperform
Price Target: $144 → $142
Current: $125.08
Upside: +13.53%
Zimmer Biomet Holdings
Oct 7, 2025
Maintains: In-Line
Price Target: $106 → $104
Current: $94.28
Upside: +10.31%
Twist Bioscience
Oct 7, 2025
Maintains: Outperform
Price Target: $46 → $42
Current: $32.30
Upside: +30.03%
Oct 7, 2025
Maintains: Outperform
Price Target: $525 → $590
Current: $572.77
Upside: +3.01%
Oct 7, 2025
Maintains: Outperform
Price Target: $108 → $106
Current: $100.79
Upside: +5.17%
Oct 7, 2025
Maintains: Outperform
Price Target: $300 → $285
Current: $300.66
Upside: -5.21%
Oct 7, 2025
Maintains: Outperform
Price Target: $1,275 → $1,400
Current: $1,414.86
Upside: -1.05%
Oct 7, 2025
Maintains: In-Line
Price Target: $535 → $450
Current: $575.34
Upside: -21.79%
Oct 7, 2025
Maintains: In-Line
Price Target: $185 → $175
Current: $178.37
Upside: -1.89%
Oct 7, 2025
Maintains: Outperform
Price Target: $64 → $68
Current: $101.06
Upside: -32.71%
Oct 7, 2025
Maintains: Outperform
Price Target: $226 → $245
Current: $226.25
Upside: +8.29%
Oct 7, 2025
Maintains: Outperform
Price Target: $115 → $110
Current: $97.52
Upside: +12.80%
Oct 7, 2025
Maintains: Outperform
Price Target: $33 → $31
Current: $18.54
Upside: +67.21%
Oct 7, 2025
Maintains: In-Line
Price Target: $128 → $140
Current: $145.49
Upside: -3.77%
Oct 7, 2025
Upgrades: Outperform
Price Target: $69 → $78
Current: $74.97
Upside: +4.04%
Sep 30, 2025
Maintains: In-Line
Price Target: $49 → $54
Current: $51.26
Upside: +5.35%
Aug 13, 2025
Maintains: Outperform
Price Target: $33 → $40
Current: $28.86
Upside: +38.60%
Aug 5, 2025
Maintains: In-Line
Price Target: $35 → $33
Current: $35.05
Upside: -5.85%
Jul 8, 2025
Maintains: Outperform
Price Target: $103 → $106
Current: $101.36
Upside: +4.58%
Jul 8, 2025
Maintains: Outperform
Price Target: $48 → $46
Current: $27.02
Upside: +70.24%
May 19, 2025
Maintains: In-Line
Price Target: $3
Current: $2.49
Upside: +20.48%
Dec 2, 2024
Upgrades: Outperform
Price Target: $18 → $30
Current: $12.11
Upside: +147.73%
Oct 1, 2024
Maintains: In-Line
Price Target: $335 → $355
Current: $394.81
Upside: -10.08%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $160
Current: $77.63
Upside: +106.11%
Oct 1, 2024
Maintains: Outperform
Price Target: $286 → $290
Current: $193.96
Upside: +49.52%
May 31, 2022
Initiates: Outperform
Price Target: $7
Current: $1.08
Upside: +548.15%